GSK Rebuts Teva’s ‘Doomsday Scenario’ On Skinny-Label Generics

Originator Urges US Supreme Court To Reject Review Of Indication Carve-Out Lawsuit

 
• By David Wallace
  
Doomsday Armageddon Apocalypse Planet Exploding
Teva’s “doomsday scenario” falls apart under scrutiny, GSK claims • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin